Epinomics

San Francisco, United States Founded: 2013 • Age: 13 yrs Acquired By 10X Genomics
Epigenomics research and development services for DNA sequencing are provided.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Epinomics

Epinomics is a company based in San Francisco (United States) founded in 2013 was acquired by 10X Genomics in August 2018. Epinomics operates in a competitive market with competitors including Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.

  • Headquarter San Francisco, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    10X Genomics

    (Aug 28, 2018)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Epinomics

Premium access

Detailed funding history for Epinomics

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Epinomics

Epinomics has secured backing from 1 investor. Prominent investors backing the company include 10X Genomics.

All
Investor Description Founded Year Domain Location
Instrument systems for genomic research and sequencing libraries are developed.
Locked Locked Locked
Premium access

Investor details for Epinomics

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Epinomics

Investments
Premium access

Investment portfolio details for Epinomics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Epinomics

Premium access

Detailed financials for Epinomics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Epinomics Comparisons

Epinomics Primary company
Description
Epigenomics research and development services for DNA sequen...
Location
San Francisco, United States
Founded Year
2013
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Epinomics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Epinomics

Epinomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Genomic database for clinical research is provided.
Locked Locked Locked
Cloud-based bioinformatics platform is offered for biotech research.
Locked Locked Locked
AI-based omics data analysis solutions are provided to researchers.
Locked Locked Locked
Developer of predictive informatics based platform for drug discovery
Locked Locked Locked
Bioinformatics platform is provided for biomarkers and drug discovery.
Locked Locked Locked
Single-molecule genetic and epigenetic sequencing solutions are provided.
Premium access

Detailed competitors of Epinomics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Epinomics

10x Genomics Acquires Epinomics
Prnewswire7 years ago
Premium access

Complete news archive for Epinomics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Epinomics

Epinomics was founded in 2013.

Epinomics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Epinomics was founded in 2013 and is based in San Francisco, United States. Operations focus on the epigenomics sector, where research and development services for DNA sequencing are offered to biotech and pharmaceutical companies. A bioinformatics tool is developed to facilitate personalized medicine via scientific research, data analytics, and clinical applications. Assistance is provided in identifying clinical biomarkers and progressing therapeutics development.

Epinomics's top competitors include Helix, Benchling and BioAge Labs.

Epinomics has 1 investor. Key investors include 10X Genomics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available